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Regulation of the lymphoid enhancer factor 1 (Lef-1) transcription factor is important for the inductive formation of many epithelial-derived
appendages including airway submucosal glands (SMGs). Although Wnts have been linked to developmental processes involving transcriptional
activation of the Lef-1 protein, there is little in vivo information directly linking Wnts with the transcriptional regulation of the Lef-1 promoter. In
the present study, we hypothesized that Wnt3a directly regulates Lef-1 gene expression required for SMG morphogenesis in mice. In support of
this hypothesis, TOPGAL reporter mice demonstrated activation of β-catenin/Tcf complexes during early phases of SMG development and
immunolocalization studies confirmed abundant expression of Tcf4, but not Tcf1 or Tcf3, at this stage. ChIP analysis in primary airway epithelial
cells revealed that Tcf4 associates with a known Wnt Responsive Region in the Lef-1 promoter and transfection of Cos-1 cells with dominant
active β-catenin and Tcf4 synergistically activated the Lef-1 promoter. Using Wnt3a deficient and Lef-1 promoter-GFP reporter mice, we also
demonstrate that Wnt3a induces Lef-1 gene expression in newly forming SMG buds of mice and is required for the maintenance of gland bud
growth. These findings provide the first in vivo evidence that Wnt3a can transcriptionally regulate the Lef-1 gene.
© 2007 Elsevier Inc. All rights reserved.Keywords: Wnt3a; TOPGAL; Lef-1; Development; Airway; Glands; Tcf4Introduction
Submucosal glands (SMGs) are epithelial secretory struc-
tures that reside beneath the airway epithelium that play im-
portant roles in hypersecretory lung diseases such as asthma,
chronic bronchitis, and cystic fibrosis (CF) (Verkman et al.,
2003). In humans, SMG hypertrophy and hyperplasia are
thought to aggravate the pathoprogression of these diseases
through excessive production of airway mucus (Salinas et al.,
2005). Hence, an understanding of the mechanisms of gland⁎ Corresponding author. Department of Anatomy and Cell Biology, University
of Iowa Department of Anatomy and Cell Biology, Room 1-111 BSB, 51
Newton Road, Iowa City, IA 52242-1109, USA. Fax: +1 319 335 7198.
E-mail address: john-engelhardt@uiowa.edu (J.F. Engelhardt).
0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.01.038growth and differentiation will allow for the development of
improved treatments of diseases that result in gland expansion
and hypersecretion. In humans, SMGs reside throughout the
cartilaginous airways of the tracheobronchial tree and in the
submucosa of the nasal passages. In mice, the development of
these structures begins as early as E15.5 for nasal submucosal
glands, while tracheal glands begin to develop during the first
few days of birth.
Epithelial appendages, like hair follicles, mammary glands,
and teeth, rely heavily on Wnt signaling pathways for proper
development. To this end, inhibiting Wnt signaling through
ectopic expression of Dkk1, a Wnt inhibitor, results in the loss
of formation of these structures (Andl et al., 2002; Chu et al.,
2004). The canonical Wnt signaling pathway consists of a
secreted Wnt signaling molecule that binds to its receptor
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binding with their cellular receptors signal a cascade of events
that leads to the inhibition of β-catenin degradation, which is
normally found associated with E-cadherin or other similar
membrane proteins, keeping free cytoplasmic and nuclear β-
catenin at low levels (Nelson and Nusse, 2004). Once stabilized
β-catenin is translocated to the nucleus where, it can associate
with transcription factors and invoke transcriptional changes by
recruiting chromatin remodeling proteins (Nusse, 2005). Target
genes of the Wnt signaling pathway include: 1) structural
proteins, such as E-cadherin or, cytokeratins (Jamora et al.,
2003; Zhou et al., 1995); 2) cellular proliferation factors, such
as cyclin D1 (Shtutman et al., 1999; Tetsu and McCormick,
1999); and 3) transcription factors, such as Lef-1 (Driskell et al.,
2004; Filali et al., 2002; Hovanes et al., 2001; Hovanes et al.,
2000; Li et al., 2006).
Lef-1 is a Tcf factor that mediates Wnt signaling by binding
with β-catenin at specific sites in the promoters of genes such as
Cyclin D1 and keratin-14 (K14) to influence cellular division
and migration (Nusse, 2005). Lef-1 knock out mice lack fully
formed hair follicles, mammary glands, teeth, and airway SMGs
(Duan et al., 1999; van Genderen et al., 1994). Misregulated
expression of this gene has also been implicated in colon cancer
in conjunction with hyperactive Wnt signaling (Hovanes et al.,
2000; Li et al., 2006). Consequently, dissecting the regulatory
mechanisms of Lef-1 expression has become imperative to
understanding a diversity of developmental processes in both
the normal and diseased states.
Attempts to elucidate the transcriptional regulation of the
Lef-1 gene have involved both in vitro and in vivo studies.
In vitro studies have revealed that transcriptional activity of
the Lef-1 gene can be modulated by the Wnt signaling pathway
and also by the transcription factor Pitx2 (Hovanes et al., 2000;
Vadlamudi et al., 2005). Early studies investigating the potential
for the Wnt pathway to induce Lef-1 gene transcription have
identified two Tcf binding sites in the Lef-1 promoter
[−1000 bp (TCTTTGCT) and −921 bp (AACAAAGA)].
These Tcf sites were shown to bind Tcf factors using in vitro
binding assays and to be necessary for upregulation of Lef-1
transcriptional activity by ectopically expressed β-catenin/Tcf
complexes (Hovanes et al., 2000). Additional studies of this
region of the Lef-1 promoter identified a separate 110 bp region
in the Lef-1 promoter, which was named the Wnt Response
Element (WRE) (−879 to −769 bp), because deletion of this
region resulted in a loss of Wnt3a inducible transcription (Filali
et al., 2002). The WRE also contains a candidate Tcf binding
site at −785 bp (ACTTTATT). The deletion of the WRE
increased the baseline transcriptional activity of the promoter,
which is consistent with this region of the promoter being
inhibitory in the absence of β-catenin (Filali et al., 2002).
Recent studies have investigated the association of Tcf factors to
these regions of the Lef-1 promoter using Chromatin Immuno-
precipitations with pan-Tcf antibodies (Li et al., 2006). These
studies suggested that Tcf factors associate preferentially with
either the WRE or the previously identified Tcf binding sites
depending on the cell type used for analysis. However, the
specific Tcf factors that associate with this area have not beenidentified. In this report, we refer to both the Tcf binding sites
(−1000 and −921 bp) and the WRE (−879 to −769 bp)
collectively as the Wnt Response Region (WRR).
The in vivo importance of the Lef-1 promoter WRE in
regulating Lef-1 gene expression has also been investigated in
transgenic Lef-1 promoter/reporter mice (Driskell et al., 2004;
Liu et al., 2004). The results of these studies suggested that the
WRE is important for controlling epithelial and mesenchymal
expression patterns of the Lef-1 promoter in hair follicles and
mammary glands (Liu et al., 2004). Studies demonstrating that
reciprocal Wnt-signals in the epithelia and mesenchyme of the
developing mammary gland are in part controlled by Lef-1,
support the potential importance of Wnt regulated Lef-1 gene
expression (Boras-Granic et al., 2006). Additionally, the Lef-1
promoter WRE was required for the inductive expression
during airway gland morphogenesis in mice (Driskell et al.,
2004). However, unlike other models of epithelial appendages,
no studies have evaluated the importance of Wnt signaling in
SMG morphogenesis. Furthermore, evidence for whether Wnts
can directly regulate the Lef-1 promoter in vivo in any organ
system has not been reported.
In the present study, we have begun to define the in vivo
regulatory mechanism that controls the induction of the Lef-1
gene during airway gland development. To this end, we have
demonstrated that the canonical Wnt signaling pathway is active
during gland bud formation using β-catenin/Tcf-βgal reporter
(TOPGAL) mice. Furthermore, using Wnt3a KO mice, we de-
monstrate that Wnt3a regulates Lef-1 protein and promoter
expression during airway SMG morphogenesis. Molecular
studies attempting to define the Wnt-regulated transcription
factors required for induction of the Lef-1 promoter demon-
strated that Tcf4 is the likely candidate in gland buds and binds
to the Lef-1 promoter WRR in primary airway cells and trans-
formed airway cell lines. In summary, these studies demonstrate
that Lef-1 gene transcription in vivo can be regulated by Wnt3a,
and places a physiologic context to this regulatory mechanism
in airway gland morphogenesis.
Materials and methods
Transgenic mice
Lef-1 deficient mice were previously described (van Genderen et al., 1994)
and Wnt3a deficient mice were kindly provided by Dr. Andy McMahon at
Harvard University (Takada et al., 1994) and were on a mixed C57BL/6J:BALB/
c background. Genotyping for these mice was performed as previously described
(Sasaki et al., 2005; Takada et al., 1994). TOPGAL mice were purchased from
Jackson Laboratories and were genotyped according to their protocol. β-
Galactosidase staining of TOPGAL mouse tissues was performed as previously
described (Driskell et al., 2004). Lef-1/GFP reporter mice were generated using
the previously described LF-2700/-200 human Lef-1 promoter fragment (−2700
to −200 bp relative to the translational start codon ATG at +1) (Filali et al., 2002)
controlling the expression of nuclear-targeted EGFP fusion protein. The
transgene cassette lacking all plasmid sequences was excised, gel purified, and
then injected into the pronucleus of fertilized oocytes of C57BL/6J×SJL/J F2
lineage. ICR pseudopregnant females were implanted with the transgenic
embryos and transgenic founders and progeny were screened by PCR analysis of
genomic DNA with the following primers: LFGFP-Fwd: 5′-CAC-GTT-ATT-
TAC-CCT-GTT-TCG-GGC-3′ and LFGFP-Rev: 5′-CAG-ATG-AAC-TTC-
AGG-GTC-AGC-TTG-3′. Transgenic mice were maintained by successive
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previously described (Driskell et al., 2004) with vaginal plugging on the
morning following evening mating defined as E0.5 days. Mice were sacrificed
and tissue was immediately frozen in Optimum Cutting Temperature Media
(OCT) and sectioned at 10 μm for immunostaining.
In vitro analysis of the Lef-1 promoter
The Cos1 cell line was transfected using Lipofectamine according to
standard protocols. A previously described expression construct (LF-2700/-200-
Luciferase) containing 2.5 kb of the human Lef-1 promoter upstream of the
firefly luciferase reporter (Vadlamudi et al., 2005) gene was used to study Tcf4/
β-catenin responsiveness of the Lef-1 promoter. LF-2700/-200-Luciferase
contains sequences in the promoter that span from −2700 to −200 bp. Cells
were grown to 70% confluency on 60-mm dishes prior to co-transfection with
1 μg LF-2700/-200-Luciferase construct and 0.5 μg of renilla luciferase plasmid
(Promega), which encoded the renilla luciferase gene under the control of the
SV40 promoter. Cells were harvested for luciferase assays at 24 h post-trans-
fection. Harvesting and analysis of lysates was performed as previously
described (Vadlamudi et al., 2005). Normalization of transfection efficiencies for
each experimental point was performed by dividing the firefly luciferase activity
units by renilla luciferase activity. The resulting value was then used to compare
the expression level of a given construct to the promoterless luciferase plasmid
backbone for the same experiment. For Tcf4 and (S37)β-catenin induction
assays, 4 μg of expression plasmids encoding Tcf4 and/or (S37)β-catenin was
cotransfected with the Lef-1 promoter-reporter and renilla luciferase constructs,
as described above. The total amount of DNA transfected in all experimental
comparisons was always normalized by the inclusion of an empty vector
plasmid control (pcDNA).
In vivo analysis of Lef-1 promoter activity in gland buds
Wnt3a+/−male mice were bred to Lef-1 promoter-EGFP reporter
female transgenic mice. Double heterozygous females were then bred to
Wnt3a+/−males and embryos were harvested at E15.5. 10 μm sections of the
snouts were obtained from littermates of Lef-1 promoter-EGFP transgene
positive embryos with either Wnt3a-KO or Wnt3a-WT genotypes (defined by
abnormalities in lower torso development and confirmed by PCR in independent
studies). Breedings typically yielded only one double transgenic Wnt3a-KO:
Lef-1-EGFP embryo and five independent breedings of this type were evaluated
using matched littermate embryos for analysis. Sections were stained with an
anti-EGFP antibody and FITC-labeled secondary antibody to localize the
nuclear targeted EGFP transgene. Serial sections of the nasal cavity were
analyzed where Lef-1 promoter activity has been shown to express in nasal
SMG buds (Driskell et al., 2004). The number of EGFP positive nuclei in each
nasal SMG bud was then quantified for matched littermate embryos. Only
regions of the glandular placode residing below the basal lamina of the surface
airway epithelium were quantified. Statistical differences were evaluated by
ANOVA followed by the Mann–Whitney test.
Western Blotting of newborn mouse tracheas and skin
Tracheas and skin were dissected from C57 postnatal day 1 (P1) mice and
immediately flash frozen in liquid nitrogen and minced in RIPA buffer. Protein
concentrations were quantified and 75 μg of protein was run on a 10.5% SDS-
PAGE gel, transferred to Nylon membranes, and probed with antibodies against
Tcf1 (SantaCruz H-18), Lef-1 (Exalpha T-100M), Tcf3 (SantaCruz M-20), and
Tcf4 (Exalpha X1070M). 293 cells were also transfected with control plasmids
overexpressing Tcf1 (Upstate 21-172), Lef-1, Tcf3 (Upstate 21-173), and Tcf4
(kind gift of Dr. James Wells). 75 μg of lysates were used as positive controls for
Western blots and demonstrated strong reactivity with the antibodies.
Chromatin immunoprecipitation
Cos1 cells were transfected in triplicate in 150 mm plates with 6 μg of
LF-2700/-200-Luciferase plasmid and either 36 μg of GFP or Tcf4V5His (kind
gift of Dr. James Wells) expression plasmids. Cells were then allowed toincubate for 24 h before harvesting the DNA for chromatin immunoprecipita-
tion. DNA harvesting and shearing was performed according to the Active Motif
DNA shearing kit (53005); 10 min incubations with the DNA shearing cocktail
resulted in consistent 300–600 bp DNA fragmentation for Cos1 cells. Pre-
cipitation and purification of DNA fragments was performed according to the
EZChIP Kit (#17-371) protocol from Upstate Biologicals. Antibodies used for
precipitation of protein/DNA complexes included control Mouse IgG, anti-Tcf4
(Exalpha X1070M), and anti-V5 (Invitrogen R960-25). Final analysis of the
precipitated DNAwas performed using Real Time PCR on 3 μl of the final DNA
precipitate. Primers used to amplify the precipitated DNA fragments included:
1) WRE Fwd: 5′-CTC-GAG-CCG-GGA-ACA-AAG-A-3′ and WRE Rev: 5′-
GGG-AAG-AGA-AAG-AGA-AGT-TTG-CC-3′ which amplified a 181 bp
fragment from −932 bp to −751 bp of the human Lef-1 promoter and 2) Cont
Fwd: 5-CAG-CGG-AGC-GGA-GAT-TAC-AG-3′ and Cont Rev: 5′-TCT-CTG-
AGT-TTC-CCA-GGG-ACC-3′ which amplified a 302 bp fragment from
−30 bp to +272 bp of the human Lef-1 gene. The base pair numbering ori-
ginates from our previous work with the Lef-1 promoter (NCBI accession
number AY129650) (Filali et al., 2002). The PCR protocol used 45 cycles of
denaturation at 95 °C for 15 sec followed by annealing at 60 °C for 45 s.
Analysis of the Real Time data was performed by calculating relative copies of
the target sequence in the immunoprecipitated fraction and dividing this number
by the copy number detected in the Input Control. Assays were done with both
specific capture antibodies and control IgG for each sample. The above protocol
was also used to analyze Tcf4 association at the endogenous Lef-1 promoter in
A549 and primary airway epithelial cells.
Immunostaining and apoptosis assays
Immunostaining was performed on 10 μm fresh frozen sections. The tissue
was then fixed in 4% paraformaldehyde for 15 min and stained with primary
antibodies for 1 h followed by incubation with the appropriate secondary
antibody for an additional hour. Control reactions were stained with secondary
antibodies only. Antibodies used for immunostaining included anti-Lef-1, anti-
Tcf4 (Exalpha X1070M), anti-GFP (Abcam ab6673), Phospho-H3 (Cell
Signaling 9701), Cyclin D1 (Abcam ab15196), and anti-K14 (Labvision
RB-2090). The rabbit polyclonal anti-human Lef-1 was generated to a His-
tagged N-terminal fusion Lef-1 protein. A BamHI and SalI fragment containing
N-terminal nucleotides 3–718 of human Lef-1 cDNA was subcloned in-frame
into the BamHI and XhoI site of the pTrcHisA vector (Invitrogen). The fusion
protein containing 238aa of Lef-1 sequence was expressed and purified from
bacteria and rabbit antisera were generated. The antibody was subsequently
affinity purified by chromatography on immobilized His-Lef-1-N238aa fusion
protein. Apoptosis was detected using the TUNEL Assay Detection kit from
R&D Systems (TA4626) on 10 μm sections from wild type and Lef-1 deficient
mice.
Results
Lef-1 expression in nasal and tracheal submucosal gland buds
Previous studies have demonstrated that Lef-1 mRNA is
induced in gland buds of developing tracheal and nasal sub-
mucosal glands in mice and ferrets (Driskell et al., 2004; Duan
et al., 1998). Additionally, transgenic mice harboring a 2.5 kb
human Lef-1 promoter-LacZ reporter express the reporter gene
selectively in gland buds of mouse trachea and nasal mucosa
(Driskell et al., 2004). These studies underscore the tight
regulation of Lef-1 expression during the development of
airway glands in a variety of species and implicate transcrip-
tional regulation of the Lef-1 gene in gland morphogenesis.
Although Lef-1 mRNA and promoter expression have been
demonstrated during gland morphogenesis, confirmation of
Lef-1 protein expression has been lacking. This has hindered
characterization of the phenotype of Lef-1 expressing cells that
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and retroviral vectors to track lineage fates in developing SMGs
have suggested that a subset of basal cells in the airway are the
progenitors of this region (Engelhardt et al., 1995). To this end,
we sought to characterize Lef-1 protein expression in develop-
ing airway glands and to determine whether they expressed the
K14 basal cell marker.
A Lef-1 antibody was generated against an N-terminal His-
tagged Lef-1 fusion protein and was analyzed for its capability
to recognize Lef-1 expression in developing airway submucosal
glands and hair follicles (as a control for well-defined patterns
of Lef-1 protein staining). Nuclear Lef-1 staining was seen in
both the nasal and tracheal epithelial gland buds (Figs. 1A–B,
E–F), while no background staining was seen in samples treated
only with secondary antibody (Figs. 1C, G). Additionally, Lef-1
protein staining was also seen in basal cells of the surface
airway nasal epithelium, a finding that mirrored mRNA expres-
sion patterns observed in nasal mucosal epithelium (Driskell et
al., 2004). These findings demonstrate a close correlation
between Lef-1 protein expression patterns in developing SMGs
and those previously observed for Lef-1 mRNA. To confirm the
specificity of our antibody, we evaluated the Lef-1 staining
pattern in the well-characterized hair follicle development
model using Lef-1 deficient P1 mouse tissue (van Genderen et
al., 1994). Wild type hair buds showed typical Lef-1 staining
patterns in the basal layer of the epidermis, the hair placode, and
the dermal condensate (Fig. 1D). In contrast, Lef-1 deficient
hair buds showed no staining in the hair follicle buds or theFig. 1. Lef-1 protein expression is upregulated in K14 positive mouse epithelial cel
evaluated in frozen sections of developing nasal (E15.5) and tracheal (P1) SMG buds
primary antibody and FITC-labeled secondary antibody or (C, G) FITC-labeled secon
Panels depict (A–C) cranial sections of E15.5 day embryos and (E–G) tracheal se
evaluated by comparing staining patterns in wild type and Lef-1 deficient P1 developi
a tracheal gland bud of newborn mouse trachea (P1). Black and white panels depict tbasal epidermal layer (Fig. 1H). With the hypothesis that glan-
dular progenitors expressing Lef-1 were derived from a subset
of basal cells (Engelhardt et al., 1995), we evaluated co-
localization of the K14 basal cell marker in Lef-1 expressing
glandular buds (Fig. 1I). Results from these studies demon-
strated that indeed Lef-1 expressing cells within the glandular
bud are K14 positive and support the hypothesis that glandular
progenitors are a subset of Lef-1/K14 co-expressing cells.
Active β-catenin/Tcf complexes are detected in developing
airway SMGs
Based on previous in vitro studies demonstrating that Wnt
signals can induce transcription from the Lef-1 promoter (Filali
et al., 2002; Hovanes et al., 2000, 2001), we hypothesized that
Wnts may also upregulate Lef-1 expression during airway gland
morphogenesis. We evaluated the in vivo status of active β-
catenin/Tcf complexes in developing airway SMGs using the
TOPGAL reporter mice commonly used to assess involvement
of Wnt signaling (DasGupta and Fuchs, 1999). TOPGAL mice
were analyzed for β-catenin/Tcf-responsive β-galactosidase
expression in their developing nasal and tracheal SMGs. Tra-
cheal gland buds, which begin to form at post-natal days P1–3,
demonstrated the highest levels of TOPGAL reporter expres-
sion in the trachea with lower basal levels of expression
throughout the surface airway epithelium (Figs. 2A and B).
Similarly, nasal gland buds, which begin to develop at the E15.5
embryo stage, also demonstrated high levels of TOPGAL ex-ls that form the developing airway SMG placode. (A–H) Lef-1 expression was
(gb) and hair follicles (P1) by immunostaining with a (A, B, D–F and H) Lef-1
dary antibody alone. Panels B–D and F–H are stained with DAPI to label nuclei.
ctions P1 newborn mice. (D and H) The specificity of the Lef-1 antibody was
ng hair follicle buds (hb). (I) Coimmunofluorescent staining for K14 and Lef-1 in
he single fluorescent channels as labeled with the merged image on the far right.
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epithelium (Figs. 2D and E). No β-gal staining was seen in
either of these two regions of the airway in TOPGAL negative
littermate control mice (Figs. 2C and E). These results support
the notion of canonical Wnt pathway involvement during
airway gland development and are consistent with the hypo-
thesis that β-catenin/Tcf activation regulates the Lef-1 promoter
in vivo.
Wnt3a is required for the induction of Lef-1 expression in
developing airway SMG placodes
Multiple studies have shown that Lef-1 promoter activity in
cell lines is induced by Wnts through the mobilization of
nuclear β-catenin (Driskell et al., 2004; Filali et al., 2002;
Hovanes et al., 2000, 2001; Li et al., 2006). However,
conclusive evidence that Wnts upregulate Lef-1 expression in
vivo has not been demonstrated. These previous in vitro studies
have implicated Wnt signaling in the regulation of the Lef-1Fig. 2. β-Catenin/Tcf pathway is activated in developing airway SMGs of
TOPGAL mice. (A–C) Tracheas were dissected from newborn TOPGAL
transgene positive (Tg+) and negative (Tg−) littermate mice (P1), stained for
β-galactosidase activity, and histologic 10 μm frozen sections were evaluated.
Tracheal SMG buds (gb) are shown for (A, B) Tg+ and (C, inset A) Tg−
littermates. (D, E) TOPGAL activity in nasal SMG buds (gb) was also analyzed
in frozen section of E15.5 embryos for (D) Tg+ and (E) Tg− littermates following
whole mount staining for β-galactosidase.promoter by identifying Tcf sites that are necessary for the
induction of Lef-1 transcription using dominant active β-
catenin/Tcf and/or Wnt signals. Sequences responsible for
Wnt3a responsiveness of the Lef-1 promoter in vitro are also
necessary for transcriptional activity of the Lef-1 promoter
during airway submucosal gland morphogenesis (Driskell et al.,
2004). In addition, it has been shown that overexpression of a
dominant active form of Lef-1, when transiently expressed, can
rescue the vestigal tail (vt) Wnt3a mutation in mice (Galceran et
al., 2001). Hence, we hypothesized that Wnt3a is required for
Lef-1 expression during airway SMG morphogenesis and that
Wnt3a deficient mice would likely lack airway SMGs, since
12 day old Lef-1 deficient mice lack nasal and tracheal glands
(Duan et al., 1999). Wnt3a knockout mice die in utero around
E16.5, so only nasal gland development could be studied
(Takada et al., 1994). To our surprise, Wnt3a deficient mice
contained properly formed nasal SMG placodes. However, as
hypothesized Wnt3a deficient mice lacked Lef-1 protein ex-
pression in SMG placodes seen in wild type littermates (Figs.
3A and B). These results demonstrated that Lef-1 expression in
developing SMGs was indeed under the control of Wnt3a, but
also conflicted with earlier reports demonstrating the lack of
SMG development in 12 day old Lef-1 deficient mice (Duan
et al., 1999). In contrast to SMGs, Wnt3a was not necessary
for Lef-1 protein expression in developing vibrissa at E15.5
(Figs. 3C and D).
To determine whether Wnt3a acted to control Lef-1 ex-
pression at the transcriptional level, we evaluated the expression
patterns of a Lef-1 promoter-EGFP reporter cassette in trans-
genic mice crossed onto the Wnt3a deficient background. This
same promoter segment was previously shown to express in
airway SMG buds and developing hair follicles at endogenous
sites of Lef-1 mRNA (Driskell et al., 2004; Liu et al., 2004).
These newly generated Lef-1 promoter-EGFP reporter trans-
genic mice express a nuclear-targeted EGFP fusion protein. As
previously described for the Lef-1 promoter LacZ reporter
transgenic mice (Driskell et al., 2004), this Lef-1 promoter
expressed nuclear targeted EGFP in the nasal gland placode
cells and sporadically in basal cells of the surface airway
epithelium of wt mice (Fig. 3E), mirroring the endogenous Lef-
1 protein expression patterns (Figs. 1A, B). In the five Wnt3a-
KO mice analyzed, sporadic expression of the Lef-1 promoter-
EGFP transgene in basal cells of the surface airway epithelium
was always observed, suggesting that control of the Lef-1 pro-
moter is not under Wnt3a control. In contrast, Wnt3a deficient
mice had significantly reduced expression of the Lef-1 pro-
moter-EGFP cassette in nasal gland placodes (Figs. 3F and 4).
However, this glandular phenotype demonstrated variable
penetrance. Quantitative assessment of five paired E15.5 double
transgenic Wnt3a-KO and Wnt3a-WT embryos demonstrated
that one Wnt3a-KO mice had normal levels of Lef-1 promoter
EGFP nuclear staining in SMG buds in comparison to its
matched littermate (Fig. 4E, group 4). The remaining four pairs
all demonstrated reduction in nuclear EGFP expression in gland
buds on the Wnt3a-KO background, with two pairs (group 3
and 5) demonstrating no detectable nuclear expression (Fig.
4E). The reason for this variability is currently unclear, but may
Fig. 3. Wnt3a regulates Lef-1 gene expression during airway SMGmorphogenesis. (A–D) Immunofluorescent detection of Lef-1 protein was evaluated in panels A, B
SMG buds and panels C and D whisker follicles from E15.5 Wnt3a deficient and wild type littermate mice. 10 μm frozen sections for each genotype were stained with
a rabbit polyclonal antibody against the N-terminal 238aa of Lef-1 and a FITC-labeled secondary antibody. (E–H) Transgenic mice harboring a 2.5 kb Lef-1 promoter-
EGFP transgene were used to assess whether Wnt3a was required for the transcriptional activation of the Lef-1 promoter in panels E, F SMG buds and panels G and H
whisker follicles from E15.5Wnt3a deficient and wild type littermate mice harboring the transgene reporter. 10 μm frozen sections for each genotype were stained with
a goat polyclonal antibody against EGFP and a FITC-labeled secondary antibody. Nomarski images are given in the bottom of panels A, B, E, and F with the basement
membrane marked by a dotted line to demarcate the glandular buds (gb). All sections were counter stained with DAPI to label nuclei (blue).
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sing the Wnt3a KO (with a C57BL/6J×BALB/c mixed lineage)
and Lef-1 reporter mice (with a C57BL/6J×SJL/J mixed line-
age). Genetic variability in modifier genes introduced into these
experiments may influence either the penetrance of the Wnt3a
phenotype and/or the regulation of the heterologous Lef-1
promoter. Despite the variable penetrance, statistical analysis of
the combined data set revealed a significant (p<0.016) decline
in the number of glandular bud cells that expressed the Lef-1
promoter in the absence of Wnt3a. These findings strongly
suggest that Wnt3a can regulate transcriptional activation of the
Lef-1 promoter during gland morphogenesis and support
findings in TOPGAL mice demonstrating active β-catenin/Tcf
complexes at sites of Wnt3a action. In contrast to findings in
SMGs, Lef-1 promoter-GFP reporter expression patterns in
both the dermal papillae and the matrix cells of whisker follicles
were similar in wild type and Wnt3a deficient littermates (Figs.
3G and H). These findings are consistent with the fact that Lef-1
protein expression in vibrissa was unaltered on the Wnt3a
deficient background and suggests that Wnt3a does not play acritical role in activating Lef-1 expression during this stage of
whisker development.
Lef-1 expression is required for maturation of SMGs but not
initiation of glandular placode formation
It has been previously reported that 12 day post-natal Lef-1
knockout mice do not have nasal or tracheal submucosal glands
(Duan et al., 1999). These previous results appeared incon-
sistent with our present findings that nasal gland placodes
formed normally in Wnt3a deficient mice despite the lack of
Lef-1 protein expression. Lef-1 is a necessary transcription
factor required for the proper formation of many epithelial
appendages (van Genderen et al., 1994). For example, hair
follicles, teeth, and mammary glands do not form properly in
Lef-1 knockout mice. Hair follicle morphogenesis occurs, but
continued development of de novo follicle formation after
E18.5 is inhibited (van Genderen et al., 1994). In addition,
mammary glands do not develop past the initial epithelial bud
stages in Lef-1 deficient mice (van Genderen et al., 1994).
Fig. 4. Wnt3a influences Lef-1 promoter activation during airway SMG
morphogenesis. (A–D) Immunofluorescent detection of nuclear-targeted EGFP
under the control of a 2.5 kb Lef-1 promoter was evaluated in SMG buds from
Wnt3a deficient and wild type littermate mice. 10 μm frozen sections for each
genotype were stained with a goat polyclonal antibody against EGFP and a
FITC-labeled secondary antibody. All sections were counter stained with DAPI
to label nuclei (blue). Panels A, C and B, D are two examples of studies
evaluating matched littermates with (A, B) Wnt3a-WT and (C, D) Wnt3a-KO
genotypes. (E) Morphometric quantification of nuclear EGFP expression in
nasal SMG buds from five independent litters. The graph depicts the mean
(±S.E.M.) number of nuclei that expressed detectable levels of nuclear EGFP in
SMG placodes for a given genotype and experiment group. The number of
placodes (n) evaluated for each animal is given above the mean value. Each
group consisted of Wnt3a-WT and Wnt3a-KO littermate embryos that were
immunostained at on the same day. All photomicrogaphs were captured at
identical time exposures and quantification was performed in the combined data
set at one time representing a total of 37 Wnt3a-Wt and 35 Wnt3a-KO gland
buds. Panels A and C were taken from group 2 and panels B and D were taken
from group 3. Statistical differences between Wnt3a-Wt and Wnt3a-KO mice
were significant as assessed by ANOVA followed by the Mann–Whitney test
(p<0.016).
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pendages, we hypothesized that Lef-1 may be required for the
continued maturation of SMGs, but not the initial stages of
placode formation. To address this hypothesis, we reevaluated
maturation of nasal and tracheal glands at earlier stages than
previously investigated. Consistent with this hypothesis, new-
born (P1) Lef-1 deficient mice did demonstrate limited nasal
submucosal gland development compared to wild type controls
(Figs. 5A–B, E–F). Nasal glands in Lef-1 deficient mice were
clearly abnormal and failed to fully develop, reminiscent offinding in hair follicles of Lef-1 deficient mice (van Genderen et
al., 1994). In contrast, tracheal gland buds were not detected
(Figs. 5C–D, G–H), confirming previous findings (Duan et al.,
1999). These results are consistent with the presence of nasal
glandular placodes in Wnt3a deficient mice lacking glandular
Lef-1 expression and suggest that Lef-1 is required for the
maintenance of SMG growth but not initiation.
Lef-1 expression has been shown to regulate cellular replica-
tion and differentiation during the morphogenesis of epithelial
appendages by influencing the expression of genes associated
with cellular proliferation and migration (Fuchs et al., 2001;
Waterman, 2004; Zhou et al., 1995). We hypothesized that
Lef-1 might also play a role in cellular proliferation during
SMG growth and development. Our analysis of phosphorylated
Histone H3 (PO4H3) expression in nasal SMGs, as a marker for
S-phase of the cell cycle, revealed a marked decrease in cellular
replication during the initial stages (E15.5) of nasal SMG
morphogenesis in Lef-1 knockout mice as compared to control
wild type littermates (Figs. 6A and B). Further analysis at later
stages of gland development (E17.5 and P1) revealed similar
findings of decreased glandular epithelial cell replication in
Lef-1 deficient mice (Figs. 6C–F). Interestingly, mesenchy-
mally derived cells surrounding glandular tubules also demon-
strated decreased PO4H3 expression on the Lef-1 knockout
background, which was most significant at E17.5 and P1 time
points (Figs. 6C–F). These findings suggest that Lef-1 is
required for normal cell cycle progression of glandular
epithelial cells. Consistent with these findings, a loss of Cyclin
D1 expression was also observed in Lef-1 deficient mice at later
stages (P1) of SMG development as compared to wild type
controls (Figs. 6H and J). Interestingly, Cyclin D1 was similarly
detected in E15.5 SMG buds of both Lef-1 knockout wild type
mice (Figs. 6G and I). These findings cumulatively suggest that
later stages of glandular proliferation are most significantly
affected by Lef-1 expression. Such findings are consistent with
the fact that both Lef-1 and Wnt3a are not required for the
initiation of gland bud formation.
Similar to SMGs, abnormal growth of mammary glands in
Lef-1 deficient mice has also been associated with a failure of
mammary epithelial placodes to progress past the initial stages
of development (van Genderen et al., 1994). Recent studies
have implicated reciprocal Wnt signals between the epithelia of
the placode and surrounding mesenchyme that are defected in
the absence of Lef-1 (Boras-Granic et al., 2006). In these studies
the progressive loss of mammary placodes in Lef-1 deficient
mice was associated with increased apoptosis of mesenchymal
cells surrounding the epithelial placodes leading to abortive
degeneration of the mammary epithelial placode. In light of
these recent results, we hypothesized that loss of cellular
proliferation in forming gland tubules caused by Lef-1 defi-
ciency may lead to reabsorption of SMG through a similar
apoptotic mechanism. To investigate this hypothesis, TUNEL
assays were performed on E15.5, E17.5 and P1 nasal glands.
Results from this analysis demonstrated TUNEL positive cells
in P1 nasal glands of Lef-1 deficient mice that were never seen
in wild type littermates (Figs. 6K–M). Interestingly, no TUNEL
labeling was observed in E15.5 or E17.5 nasal buds of Lef-1
Fig. 5. Lef-1 expression is not required for nasal SMG placode formation but is
required for maturation of glands. The presence of nasal and tracheal glands
were evaluated in P1 (A–D) wild type and (E–H) Lef-1 deficient mice by
evaluating 10 μm H&E stained frozen sections. Nasal SMGs with normal
morphology were seen in the submucosa of (A, B) wild type animals, while
SMGs in the mucosa of (E, F) Lef-1 deficient mice failed to undergo normal
tubulogenesis. Boxed regions in panels A and E are enlarged in panels B and F,
respectively. Tracheal SMG buds were found in the proximal trachea of (C, D)
wild type animals, while no SMG buds were found in panels G, H Lef-1
deficient mice. Boxed regions in panels C and G are enlarged in panels D and H,
respectively. SMG, submucosal glands; gb, gland bud; ns, nasal septum.
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with apoptotic cell death as a mechanism for SMG clearance
when Lef-1 is absent and cellular proliferation is abrogated.
Tcf4 mediates Wnt activation of the Lef-1 promoter in airway
epithelia
Tcfs have been shown to bind the Lef-1 promoter in vitro
(Hovanes et al., 2001) and in vivo (Li et al., 2006) through
association at the WRR. Tcf factors can bind to similar DNA
sequences and regulate context-specific activation and/or
repression of diverse promoters (Waterman, 2004). An example
of these opposing effects is seen in the contrasting phenotypes
found in Tcf1 or Tcf4 null mice. Tcf4 null mice lack intestinal
crypt progenitor cells due to a loss of proliferation in the cryptstem cell compartment, indicating that the expression of Tcf4
can play a important in vivo role in cellular proliferation
(Korinek et al., 1998; Roose et al., 1999). In contrast, Tcf1 null
mice exhibited increased susceptibility to neoplasms in their
intestines and mammary glands, suggesting an inhibitory role in
proliferation (Roose et al., 1999; Verbeek et al., 1995). Con-
sequently, it is important to define the Tcf factor(s) that bind to
the Lef-1 promoter WRR to fully understand Wnt involvement
in SMG morphogenesis. To better define the transcription
factors involved in Wnt3a activation of the Lef-1 promoter
within airway epithelial cells, we sought to identify candidate
Tcf factors present in airway epithelia and test whether these
factors associate with the Lef-1 promoter WRR, which contains
known Tcf bindings sites as well as the WRE required for
Wnt3a activation in vitro. As a first assessment, Western blots
were performed to detect levels of Tcf1, 3, 4 and Lef-1 in whole
cell lysates from trachea and skin. In addition to Lef-1, Tcf4 was
detected in newborn (P1) skin and tracheal lysates, but Tcf1 and
3 were absent (Fig. 7A). Immunostaining of P1 newborn
tracheas confirmed that indeed Tcf4 expression localized to the
surface airway epithelium (SAE) as well as the airway SMG
placodes (Fig. 7D), while Tcf1, and Tcf3 were not expressed
(Figs. 7B and C). Immunostaining of E15.5 embryos also
demonstrated Tcf4 expression in nasal gland buds (Fig. 7F),
while control experiments omitting primary antibody gave no
detectable staining (Fig. 7E). These results identify Tcf4 as a
potential candidate for Wnt3a mediated activation of the Lef-1
promoter during airway gland development. Tcf4 expression in
SMG buds and SAE was unaffected by deletion of Lef-1 or
Wnt3a (Figs. 7G and H). Given that Lef-1 is required for normal
glandular development and its expression is dependent on
Wnt3a, these findings indicating that Tcf4 cannot compensate
for Lef-1 specific function during the morphogenesis of SMGs.
Given that Tcf4 is expressed in developing airway SMGs, and
Tcf4 in conjunction with nuclear β-catenin has been shown to
activate Lef-1 promoter activity, we hypothesized that Tcf4
associates with the WRR in the Lef-1 promoter. Indeed, recently
studies have demonstrated that Tcf factors bind to the WRR in a
cellular context-specific fashion using Chromatin Immunopre-
cipitation (ChIP) (Li et al., 2006). However, the specific Tcf
factors that associated with this region of the Lef-1 promoter
were not elucidated. Furthermore, the specific 2.5 kb promoter
fragment used in our studies has not been previously evaluated
for Tcf responsiveness (Driskell et al., 2004; Filali et al., 2002;
Hovanes et al., 2001). To confirm that previous findings of TCF/
β-catenin-dependent Lef-1 promoter transcription (Hovanes et
al., 2001) also applied to the larger 2.5 kb Lef-1 promoter studied
in our transgenic models, we investigated the ability of Tcf4 and
a dominant active mutant of β-catenin (S37) to induce the Lef-1
promoter in transient transfection assays in Cos1 cells (the same
cell line previously used to study Tcf/β-catenin-dependent Lef-1
promoter transcription). Indeed, Tcf4 and β-catenin-S37
synergistically induced transcription from the 2.5 kb Lef-1
promoter (Fig. 8B), consistent with previous observation with a
shorter promoter (Hovanes et al., 2001).
Although purified Tcf proteins have been shown to bind and
associate with the Lef-1 promoter at the WRR, identification of
Fig. 6. SMGbuds and tubules fail to develop in the absence of Lef-1 due to impaired cellular proliferation. To investigate potential mechanisms responsible for improper
SMG maturation in Lef-1 deficient mice, we evaluated expression of two markers for cellular proliferation and the extent of apoptosis in Lef-1 deficient and wild type
littermate nasal SMGs at E15.5, E17.5, and P1 developmental time points. Immunostaining for phosphorylated histone H3 (PO4H3) and Cyclin D1 revealed difference
in the extent of cellular replication in developing nasal SMG buds (gb), tubules (TB), and mesenchymal cells (M) between Lef-1 deficient and wild type mice. (A–J)
Indirect immunofluorescent staining with FITC-labeled secondary antibodies for (A–F) PO4H3 or (G–J) Cyclin D1 in wild type (+/+) and Lef-1 deficient (−/−)
littermate nasal tissue sections for the indicated developmental time points and genotypes. (K–M) TUNEL assays were also performed on P1 nasal SMGs of (K) wild
type and (L, M) Lef-1 deficient littermates. No TUNEL labeling was observed in wild type SMGs, however, TUNEL positive nuclei (green) were observed in Lef-1
deficient glandular bud epithelial cells (gb) and also in cells below the basement membrane no longer associated with visible buds in regions where glandular structures
normally form (data not shown).Merged FITC images with DAPI nuclear counter stain are given in all panels. The basal lamina of epithelia in the surface airway (SAE),
glandular buds, and glandular tubules is marked by a dashed white line when appropriate.
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tigated. Using ChIP, we sought to demonstrate that Tcf4 asso-
ciates with the WRR of the Lef-1 promoter in vivo. Because of
the low resolution of ChIP assays caused by random DNA
shearing, and the close proximity of known Tcf binding sites
with the WRE, these studies can not distinguish between bin-
ding at these two regions and can only determine association of
the overall WRR. ChIP was performed in Cos1 cells transiently
transfected with a Lef-1 promoter/reporter plasmid and Tcf4
expression plasmids that expressed V5-tagged Tcf4. Using
capture antibodies against either Tcf4 or V5, results de-
monstrated a ∼19–20 fold enrichment of Tcf4 binding to the
WRR of the Lef-1 promoter in cells overexpressing the Tcf4construct in comparison to cells transfected with a GFP
construct (Fig. 8C). These findings demonstrate a correlation
between Tcf4/β-catenin transcriptional induction of the 2.5 kb
Lef-1 promoter and Tcf4 binding to the promoter's WRR. Fur-
thermore, given that Tcf4 levels are extremely low in Cos1 cells
(Hovanes et al., 2001), these findings demonstrate the speci-
ficity of our Tcf4 antibody directed ChIP assay. Using this
validated ChIP assay, we then sought to determine if endo-
genous Tcf4 in airway epithelial cells also associated with the
endogenous Lef-1 promoter. Indeed results from these studies
demonstrated significant enrichment of Tcf4 binding to the
endogenous Lef-1 promoter WRR in both A549 transformed
airway cells and primary airway epithelial cells as compared to
Fig. 7. Tcf4 is highly expressed in developing airway epithelium and SMGs and is unaltered by Wnt3a or Lef-1 deficiency. To investigate candidate Tcfs that might be
responsible for Wnt-mediated activation of the Lef-1 gene during glandular development, we evaluated the expression patterns of Tcf1, 3, and 4 in developing trachea
and nasal epithelium. (A) Western blot analysis for Lef-1, Tcf1, 3 and 4 was evaluated using 75 μg of protein lysate from 293 cells transiently transfected with the
expression constructs indicated above each lane (lane 1–4) and also in tissue harvested from skin and trachea of newborn mice (P1) (lane 5 and 6). (B–D)
Immunostaining for the indicated Tcf proteins was performed on P1 tracheal gland buds using primary Tcf antibodies as indicated in the methods and FITC-labeled
secondary antibody (left panel). Merged FITC images with DAPI counter stain are given to the right of each panel. (E) P1 tracheal epithelium was stained with only the
FITC secondary antibody used for Tcf4 detection. (F–H) Nasal SMGs from wild Type, Wnt3a deficient, and Lef-1 deficient E15.5 embryos were immunostained for
Tcf4 expression and demonstrated expression in the nasal epithelium and nasal SMG bud (gb). The basal lamina of the surface airway epithelium and glandular bud
epithelium is marked by a dashed white line.
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(Figs. 8D and E). In contrast, no detectable Tcf4 association was
observed on a segment of the Lef-1 gene ∼700 bp 3′ to the
WRR (Fig. 8E) These results confirm that Tcf4 does bind to the
Lef-1 promoter in airway epithelial cells in vivo within the
vicinity of the WRR. Since this WRE is known to be required
for Lef-1 promoter expression during SMG morphogenesis
(Driskell et al., 2004), these findings support the notion that
Tcf4 is involved in regulating Lef-1 gene expression in airway
cells during SMG development.
Discussion
Lef-1 plays a dynamic role in many developmental pro-
cesses, of which the best studied are those involved in
regulating epithelial skin appendages including hair follicles
and mammary glands. Pathways that control Lef-1 activation
have been best studied at the level of post-transcriptional re-gulation. In this context, Wnt signals play a major role in
mobilizing the co-activator β-catenin to the nucleus to
facilitate Lef-1 activation as a transcription factor. A second
less characterized pathway for Lef-1 activation during orga-
nogenesis in vivo includes transcriptional activation of the
Lef-1 promoter (Widelitz, 2004). In this context, transgenic
mice harboring Lef-1 promoter reporters have demonstrated
that transcriptional regulation of the Lef-1 gene can be highly
regulated during hair follicle, mammary gland, and SMG
development (Driskell et al., 2004; Liu et al., 2004). Addi-
tionally, Lef-1 transcriptional regulation appears to play an
important role in the development of colon cancers (Hovanes
et al., 2001). These studies evaluating Lef-1 promoter activa-
tion in transgenic mice and cancers have implicated Wnt/Tcf/
β-catenin signaling pathways as important in the regulation of
Lef-1 gene transcription during development. However, to
date, there has been no direct evidence demonstrating Wnts
can indeed control Lef-1 gene transcription in vivo in the
Fig. 8. Tcf4 mediates Wnt signaling at the WRR in the Lef-1 promoter. (A) A schematic of the Lef-1 promoter (not drawn to scale) with candidate Tcf binding sites
[−1000 bp (TCTTTGCT), −921 bp (AACAAAGA), and −785 bp (ACTTTATT)] and WRE illustrated. Regions of the Lef-1 promoter evaluated in ChIP assays by
real time PCR are marked below the promoter diagram with bp locations of the end primers. PCR product (I) amplifies the WRR region and PCR product (II) amplifies
a region downstream of Tcf binding sites. (B) To determine if Tcf4/beta-catenin can induce the transcriptional activity of the 2.5 kb Lef-1, Cos1 cells were cotransfected
with the LF-2700/-200-Luciferase plasmid and dominant active β-catenin (S37) and/or Tcf4 expression plasmids. Whole cell lysates were collected 24 h post
transfection and analyzed for luciferase activity. Results depict the mean±S.E.M. for N=3 transfections. (C) To determine if Tcf4 associates with the WRR of the
LF-2700/-200 Lef-1 promoter, Cos1 cells were cotransfected with the LF-2700/-200-Luciferase plasmid together with either a Tcf4-V5-His-tagged or GFP expression
plasmid. Nuclear cell lysates were collected 24 h after transfection and ChIP assays were performed using either anti-Tcf4 or anti-V5 antibodies. Mouse IgG was used
as a negative control for immunoprecipitation in the ChIP assay. PCR product (I) primers were used for Real Time PCR analysis of immunoprecipitates. The results are
presented as fold enrichment of relative PCR product (I) copies detected in anti-Tcf4 or anti-V5 precipitates over the relative PCR product (I) copies detected in Mouse
IgG precipitates. (D) Tcf4 association at the WRR of the endogenous Lef-1 promoter was analyzed in A549 cells by performing ChIP assays on A549 nuclear cell
lysates with either anti-Tcf4 antibody or Mouse IgG control. Real Time PCR analysis was performed using probes for PCR product (I) and is presented as relative
copies. (E) Tcf4 association at the WRR in the Lef-1 promoter in undifferentiated and differentiated primary airway epithelial was assessed by ChIP. Real Time PCR
analysis was preformed using probes to PCR product (I) and (II) and using the indicated antibodies for precipitation.
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provide this evidence by demonstrating that Lef-1 gene ex-
pression is regulated by Wnt3a in the context of SMG de-
velopment. Such information may also lead to an enhanced
understanding of other developmental systems involving Wnt
signaling and the regulation of Lef-1 dependent processes.Although Lef-1 is required for skin appendage and airway
SMG development, notable differences can be found between
the types of cells that express Lef-1 during the morphogenesis
of these structures. In hair follicles and mammary glands, Lef-1
is expressed in a dynamic fashion in both the epithelial placode
and surrounding mesenchymal cells leading to reciprocal
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expression during SMG development is limited to epithelial
cells of the placode and developing glandular tubules, sug-
gesting that fundamental differences exist in the developmental
biology of SMGs and skin appendages. Despite these differ-
ences, it appears that Lef-1 may have a similar functional role in
both hair follicle and SMG morphogenesis, since like hair
follicle (Fuchs et al., 2001; Millar et al., 1999), SMG formation
is also inhibited in the absence of Lef-1 due to the repressed
ability of cells in the forming appendage to proliferate.
Our findings assessing SMG development in Wnt3a
deficient mice implicate Wnt signaling in the regulation of
Lef-1 gene transcription. Although the loss of Wnt3a did not
lead to the inhibition of placode formation as we originally
hypothesized, the loss of Lef-1 expression led to the eventual
regression of SMGs through the lack of cellular proliferation.
A multitude of Wnts are expressed during the formation of
epithelial appendages and the compensatory nature of these
proteins are thought to contribute to the lack of epithelial
appendage phenotypes during embryogenesis when any one
Wnt gene is deleted. For example, the hair follicle expresses at
least 3 Wnts during placode formation and as many as 6
different Wnts during maturation and cycling, including
Wnt3a (Reddy et al., 2001). Consequently, deletion of a
single Wnt gene often does not result in a grossly abnormal
epithelial appendage phenotype. These findings may also help
to explain why variable penentrance in Wnt3a regulation of
the Lef-1 promoter was seen on a mixed outbred genetic
background.
It has been previously reported that 12 day old Lef-1
knockout mice lack airway SMGs in the nasal mucosa and
trachea (Duan et al., 1999). In the present study, we have
demonstrated that nasal gland buds do indeed form in Lef-1
deficient mice, however they fail to undergo normal tubulogen-
esis since cellular proliferation is abrogated by the absence of
Lef-1. This observation mirrors (Sasaki et al., 2005) the loss of
proliferative markers during hair follicle development of Lef-1
knockout mice (Millar et al., 1999; Zhou et al., 1995). The
observation of SMG apoptosis in Lef-1 deficient mice, which is
most likely a downstream consequence caused by a lack cellular
proliferation, is shared with several other development path-
ways. For example, the progressive loss of mammary placodes
in Lef-1 knockout mice leads to increased apoptosis of mesen-
chymal cells surrounding the epithelial placodes (Boras-Granic
et al., 2006). Similarly, during tooth development in Lef-1
knockout mice at E16.5 is accompanied by apoptosis in the
dental epithelium (Sasaki et al., 2005). In B cells, Lef-1
functions to also promote cell survival, with increased apoptosis
observed in Lef-1 deficient mice (Reya et al., 2000; Boras-
Granic et al., 2006). However, these observations differ from
what is seen in hair follicles, where no additional apoptosis was
seen in Lef-1 knockout mice compared to wild type controls
(data not shown). These findings suggest that Lef-1 plays organ
specific roles in the maintenance of morphogenesis of diverse
developmental programs.
Wnt activation of Lef-1 promoter reporter constructs in vitro
is dependent on Tcf/β-catenin signaling and Wnt responsivesequences in the promoter that contain Tcf binding sites (Filali
et al., 2002; Hovanes et al., 2000, 2001; Li et al., 2006). Our
studies also demonstrate that Tcf4/β-catenin complexes can
activate Lef-1 transcriptional activity and that Tcf4 also
associates with regions in the Lef-1 promoter that have been
assigned to Wnt signaling. The WRE in the Lef-1 promoter,
which may work in conjunction with Tcf binding sites, is
required for transcriptional activation of a heterologous Lef-1
promoter in SMGs (Driskell et al., 2004; Liu et al., 2004).
Hence, our studies demonstrate for the first time Tcf4 asso-
ciation with the endogenous Lef-1 promoter at sites responsible
for transcriptional activation of the promoter in nasal and
tracheal SMGs and Wnt3a activation of the promoter in vitro
(Filali et al., 2002). In vivo supportive evidence for the impor-
tance of Wnt3a in activating the Lef-1 promoter in epithelial
cells of the SMG placode is three-fold. First, endogenous Lef-1
protein fails to be induced in SMG placodes in Wnt3a deficient
mice. Second, the TOPGALTcf/β-catenin reporter is induced at
highest levels in SMG placodes of mice. Finally, Wnt3a
influenced transcriptional activation of the Lef-1 promoter in
epithelial cells of the SMG placode. Tcf4 appears to be the
likely candidate for Wnt3a-mediated activation of the Lef-1
gene during SMG morphogenesis since it is expressed at high
levels in gland buds and binds to the Lef-1 promoter in the
vicinity of the WRE. Given that Tcf4 is ubiquitously expressed
in the airway epithelial cells and is unaltered on the Wnt3a
deficient background (Fig. 7G), it is likely that Wnt3a regulates
Lef-1 transcription through the local activation of β-catenin in
the forming SMG placode. This hypothesis is supported by the
fact that co-expression of dominant active β-catenin and Tcf4
synergistically enhance transcription from the Lef-1 promoter.
Given that Tcf4 expression is also unaltered on the Lef-1
deficient background (Fig. 7H), it also appears that Tcf4
expression cannot compensate for Lef-1 during SMG morpho-
genesis. However, further investigation is needed to determine
if Tcf4 and β-catenin are absolutely required for Wnt3a
induction of the Lef-1 promoter in vivo during airway SMG
development.
In conclusion, these studies describe the first report of Wnt-
mediated transcriptional activation of the Lef-1 promoter in
vivo. Such findings provide further insights into the diverse
mechanisms by which Lef-1 regulation controls developmental
processes. Further elucidation of these mechanisms may un-
cover additional regulatory systems that control Lef-1 transcrip-
tion in response to diverse Wnt signals in both development and
cancer.
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